Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience

BACKGROUND: The spectrum of Coronavirus Disease 2019 (COVID-19) is broad and thus early appropriate risk stratification can be helpful. Our objectives were to define the frequency of myocardial injury using high-sensitivity cardiac troponin I (hs-cTnI) and to understand how to use its prognostic abi...

Descripción completa

Detalles Bibliográficos
Autores principales: De Michieli, Laura, Babuin, Luciano, Vigolo, Stefania, Berti De Marinis, Giulia, Lunardon, Alessandro, Favretto, Francesco, Lobo, Ronstan, Sandoval, Yader, Bryant, Sandra C., Donato, Daniele, Plebani, Mario, Vettor, Roberto, Iliceto, Sabino, Cianci, Vito, Jaffe, Allan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Canadian Society of Clinical Chemists. Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847286/
https://www.ncbi.nlm.nih.gov/pubmed/33529580
http://dx.doi.org/10.1016/j.clinbiochem.2021.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847286/
https://www.ncbi.nlm.nih.gov/pubmed/33529580
http://dx.doi.org/10.1016/j.clinbiochem.2021.01.006

Ejemplares similares